These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39226883)

  • 1. Safety and Efficacy Comparison of Tenecteplase and Alteplase for Clinically Suspected Large Vessel Occlusion Strokes without Thrombectomy.
    Lo WT; Fong WC; Chau CSK; Ismail M; Li JTC; Chan CC; Chan CHS; Chan CY; Chan GH; Chan AL; Wong MS; Kwok WYV; Or HF; Chan ST; Fong CS; Chan NM; Cheung YF
    Cerebrovasc Dis Extra; 2024; 14(1):134-140. PubMed ID: 39226883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous alteplase versus tenecteplase in patients with acute posterior circulation strokes: A secondary analysis from the AcT randomized controlled trial.
    Cimflova P; Alhabli I; Bala F; Horn M; Benali F; Buck BH; Catanese L; Coutts PSB; Khosravani H; Appireddy R; Tkach A; Dowlatshahi D; Carpani F; Field T; Hunter G; Hill PMD; Poppe AY; Ademola A; Shamy M; Sajobi TT; Swartz RH; Almekhlafi MA; Menon PBK; Singh N
    J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107985. PubMed ID: 39222700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early recanalization after tenecteplase versus alteplase: Experience in a large stroke network.
    Karamchandani RR; Asimos AW; Strong D; Rhoten JB; Clemente JD; Defilipp G; Bernard JD; Stetler WR; Parish JM; Hines AU; Patel HN; Helms AM; Macko L; Retelski J; Williams L; Guzik AK; Wolfe SQ; Patel NM
    J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107931. PubMed ID: 39147079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.
    Gerschenfeld G; Turc G; Obadia M; Chausson N; Consoli A; Olindo S; Caroff J; Marnat G; Blanc R; Ben Hassen W; Seners P; Guillon B; Wiener E; Bourcier R; Yger M; Cho TH; Checkouri T; Gory B; Smadja D; Sibon I; Richard S; Piotin M; Eker OF; Pico F; Lapergue B; Alamowitch S;
    Neurology; 2024 Jul; 103(1):e209398. PubMed ID: 38862134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Intravenous Tenecteplase Versus Alteplase in Treating Acute Ischemic Stroke With Diabetes and Admission Hyperglycemia.
    Liu H; Jin A; Pan Y; Meng X; Li H; Li Z; Wang Y; Li S
    J Am Heart Assoc; 2024 Oct; 13(20):e036393. PubMed ID: 39392168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
    Bala F; Singh N; Buck B; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Appireddy R; Moreau F; Phillips S; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Williams H; Field TS; Manosalva Alzate A; Siddiqui M; Zafar A; Imoukhoude O; Hunter G; Alhabli I; Benali F; Horn M; Hill MD; Shamy M; Sajobi TT; Swartz RH; Menon BK; Almekhlafi M
    JAMA Neurol; 2023 Aug; 80(8):824-832. PubMed ID: 37428494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.
    Muir KW; Ford GA; Ford I; Wardlaw JM; McConnachie A; Greenlaw N; Mair G; Sprigg N; Price CI; MacLeod MJ; Dima S; Venter M; Zhang L; O'Brien E; Sanyal R; Reid J; Sztriha LK; Haider S; Whiteley WN; Kennedy J; Perry R; Lakshmanan S; Chakrabarti A; Hassan A; Marigold R; Raghunathan S; Sims D; Bhandari M; Wiggam I; Rashed K; Douglass C;
    Lancet Neurol; 2024 Nov; 23(11):1087-1096. PubMed ID: 39424558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial.
    Parsons MW; Yogendrakumar V; Churilov L; Garcia-Esperon C; Campbell BCV; Russell ML; Sharma G; Chen C; Lin L; Chew BL; Ng FC; Deepak A; Choi PMC; Kleinig TJ; Cordato DJ; Wu TY; Fink JN; Ma H; Phan TG; Markus HS; Molina CA; Tsai CH; Lee JT; Jeng JS; Strbian D; Meretoja A; Arenillas JF; Buck BH; Devlin MJ; Brown H; Butcher KS; O'Brien B; Sabet A; Wijeratne T; Bivard A; Grimley RS; Agarwal S; Munshi SK; Donnan GA; Davis SM; Miteff F; Spratt NJ; Levi CR;
    Lancet Neurol; 2024 Aug; 23(8):775-786. PubMed ID: 38880118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials.
    Xiong Y; Wang L; Li G; Yang KX; Hao M; Li S; Pan Y; Wang Y
    Stroke Vasc Neurol; 2024 Aug; 9(4):360-366. PubMed ID: 37640500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
    Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenecteplase versus alteplase before stroke thrombectomy: outcomes after system-wide transitions in Pennsylvania.
    Hendrix P; Gross BA; Allahdadian S; Sioutas GS; Koul P; Tarbay AC; Lang MJ; Srinivasan VM; Al-Bayati AR; Li J; Noto A; Nogueira RG; Burkhardt JK; Zand R; Schirmer CM
    J Neurol; 2024 Aug; 271(8):5637-5641. PubMed ID: 38960948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world comparative safety and efficacy of tenecteplase
    Psychogios K; Palaiodimou L; Katsanos AH; Magoufis G; Safouris A; Kargiotis O; Spiliopoulos S; Papageorgiou E; Theodorou A; Voumvourakis K; Broutzos E; Stamboulis E; Tsivgoulis G
    Ther Adv Neurol Disord; 2021; 14():1756286420986727. PubMed ID: 33488774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Endovascular Thrombectomy with and without Thrombolysis for Acute Large Artery Ischaemic Stroke at a Tertiary Stroke Centre.
    Wee CK; McAuliffe W; Phatouros CC; Phillips TJ; Blacker D; Singh TP; Baker E; Hankey GJ
    Cerebrovasc Dis Extra; 2017; 7(2):95-102. PubMed ID: 28463832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
    JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.